IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
36 hedge funds and large institutions have $141M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-6
Holders Change %
-14.29%
% of All Funds
0.61%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
8
Increased
4
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
$1.35M |
| 2 |
Millennium Management
New York
|
$1.34M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
$1.28M |
| 4 |
LCM
Laurion Capital Management
New York
|
$1.16M |
| 5 |
LM
Lasry Marc
|
$3.81M |
